• Sera Prognostics joined a UC San Diego-led consortium awarded up to $10.4 million from ARPA-H’s MOCS program.
• Allegro MicroSystems also participates in the project to develop a point-of-care test to assess fetal hypoxia risk from maternal blood.
• Sera will support biomarker discovery and validation for potential integration into a rapid testing platform for labor and delivery decisions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sera Prognostics Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202606241605PR_NEWS_USPR_____LA91456) on June 24, 2026, and is solely responsible for the information contained therein.